ELVN
Enliven Therapeutics, Inc.
+1.73 (+3.53%)50.86USD913K成交股數3.7B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 29.0M | 20.7M | 21.2M | 18.2M | 21.5M | 24.9M | 21.3M | 18.8M | 20.0M | 17.9M | 19.6M | 15.2M |
| 銷售管理費用 | 8.2M | 7.1M | 13.0M | 6.9M | 7.1M | 6.8M | 5.8M | 5.8M | 6.0M | 4.8M | 4.6M | 5.0M |
| 營業利益 | −37.2M+30% | −27.8M-12% | −34.3M+27% | −25.1M+2% | −28.6M+10% | −31.7M+39% | −27.1M+12% | −24.6M+22% | −26.0M | −22.7M | −24.2M | −20.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −32.5M+28% | −23.6M-17% | −29.7M+28% | −20.1M+1% | −25.3M+11% | −28.5M+47% | −23.2M+11% | −20.0M+19% | −22.7M | −19.4M | −20.8M | −16.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.490% | -0.38-33% | -0.45-6% | -0.32-22% | -0.49-9% | -0.57+97% | -0.48-6% | -0.410% | -0.54 | -0.29 | -0.51 | -0.41 |
| 稀釋股數 | 66.2M | 62.8M | 56.7M | 62.1M | 52.1M | 50.1M | 48.3M | 48.1M | 42.0M | 35.5M | 41.0M | 41.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 136M | 132M | 98.9M | 102M | 119M | 102M | 101M | 96.9M | 149M | 100M | 73.8M | 126M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 910M | 465M | 476M | 491M | 504M | 303M | 305M | 327M | 343M | 272M | 274M | 289M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 15.1M | 11.5M | 16.6M | 14.8M | 15.4M | 14.3M | 17.0M | 22.1M | 25.1M | 26.0M | 12.3M | 9.5M |
| 股東權益 | 895M | 453M | 460M | 476M | 488M | 288M | 288M | 305M | 318M | 246M | 262M | 279M |
| 負債比 | 1.7% | 2.5% | 3.5% | 3.0% | 3.1% | 4.7% | 5.6% | 6.8% | 7.3% | 9.5% | 4.5% | 3.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −19.3M-20% | – | – | – | −24.1M | – | – | −23.4M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 20K | – | – | 20K | – | – | – |
| 自由現金流 | – | −19.3M-20% | – | – | – | −24.1M | – | – | −23.4M | – | – | – |
| 折舊攤銷 | 7K | 14K | 83K | 62K | 81K | 74K | 80K | 79K | 79K | 80K | 79K | 74K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −104M | –% | -1.83 | −70.5M |
| FY2024 | – | – | −89.0M | –% | -1.89 | −73.2M |
| FY2023 | – | – | −71.6M | –% | -2.01 | −61.4M |
| FY2022 | – | – | −37.7M | –% | -12.05 | −32.7M |
| FY2021 | – | – | −24.7M | –% | -10.73 | −19.3M |
| FY2020 | – | – | −41.4M | –% | -3.53 | −37.4M |
| FY2019 | – | – | −23.5M | –% | -33.40 | −22.0M |